342 related articles for article (PubMed ID: 17182232)
1. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of N-acyl-2-(5-fluorouracil-1-yl)-D,L-glycine as a colon-specific prodrug of 5-fluorouracil.
Lee JS; Jung YJ; Kim YM
J Pharm Sci; 2001 Nov; 90(11):1787-94. PubMed ID: 11745736
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro evaluation of N-nicotinoylglycyl-2-(5-fluorouracil-1-yl)-D,L-glycine as a colon-specific prodrug of 5-fluorouracil.
Lee J; Rho J; Yang Y; Kong H; Jung Y; Kim Y
J Drug Target; 2007 Apr; 15(3):199-205. PubMed ID: 17454357
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
Sun W; Zhang N; Li A; Zou W; Xu W
Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
[TBL] [Abstract][Full Text] [Related]
5. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.
Ribeiro L; Silva N; Iley J; Rautio J; Järvinen T; Mota-Filipe H; Moreira R; Mendes E
Arch Pharm (Weinheim); 2007 Jan; 340(1):32-40. PubMed ID: 17206608
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
[TBL] [Abstract][Full Text] [Related]
7. 1-Alkylcarbonyloxymethyl prodrugs of 5-fluorouracil (5-FU): synthesis, physicochemical properties, and topical delivery of 5-FU.
Taylor HE; Sloan KB
J Pharm Sci; 1998 Jan; 87(1):15-20. PubMed ID: 9452962
[TBL] [Abstract][Full Text] [Related]
8. Conversion of a novel 5-fluorouracil (5-FU) derivative to 5-FU in rats.
Takada K; Yoshikawa H; Muranishi S
Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):99-108. PubMed ID: 6867473
[TBL] [Abstract][Full Text] [Related]
9. Covalently mucoadhesive amphiphilic prodrug of 5-fluorouracil for enhanced permeation and improved oral absorption.
Liu Y; Zhao D; Sun M; Wei W; Wang Y; Zhou J; Zhang R; Wang J; Zhang H; He Z; Kan Q; Sun J
Drug Deliv Transl Res; 2018 Jun; 8(3):645-656. PubMed ID: 29532356
[TBL] [Abstract][Full Text] [Related]
10. Topical delivery of 5-fluorouracil (5-FU) by 1,3-bisalkylcarbonyl-5-FU prodrugs.
Beall HD; Sloan KB
Int J Pharm; 2002 Jan; 231(1):43-9. PubMed ID: 11719012
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of N-nicotinoyl-2-{2-(2-methyl-5-nitroimidazol-1-yl)ethyloxy}-D,L-glycine as a colon-specific prodrug of metronidazole.
Kim D; Hong S; Jung S; Jung Y; Kim YM
J Pharm Sci; 2009 Nov; 98(11):4161-9. PubMed ID: 19283770
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravitreal 5-fluorouracil prodrugs in silicone oil: experimental studies in pigs.
Schmidt Laugesen C; Steffansen B; Scherfig E; la Cour M
Acta Ophthalmol Scand; 2005 Apr; 83(2):184-90. PubMed ID: 15799730
[TBL] [Abstract][Full Text] [Related]
13. Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation.
Tammara VK; Narurkar MM; Crider AM; Khan MA
J Pharm Sci; 1994 May; 83(5):644-8. PubMed ID: 8071813
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol.
Kumpulainen H; Järvinen T; Mannila A; Leppänen J; Nevalainen T; Mäntylä A; Vepsäläinen J; Rautio J
Eur J Pharm Sci; 2008 Jul; 34(2-3):110-7. PubMed ID: 18403185
[TBL] [Abstract][Full Text] [Related]
15. Solubility and solution stability studies of different amino acid prodrugs of bromhexine.
Aggarwal AK; Gupta M
Drug Dev Ind Pharm; 2012 Nov; 38(11):1319-27. PubMed ID: 22283553
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, enzymatic hydrolysis and physico-chemical properties of N-substituted 4-(aminomethyl)benzoate diester prodrugs of ganciclovir.
Jensen E; Bundgaard H
Acta Pharm Nord; 1991; 3(4):243-7. PubMed ID: 1781915
[TBL] [Abstract][Full Text] [Related]
17. Nonlinear pharmacokinetics of 5-fluorouracil in rats.
Jarugula VR; Lam SS; Boudinot FD
J Pharm Sci; 1997 Jun; 86(6):756-8. PubMed ID: 9188061
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and stability of dendrimer prodrugs.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2006 Feb; 308(1-2):175-82. PubMed ID: 16384673
[TBL] [Abstract][Full Text] [Related]
19. Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs.
Beall HD; Sloan KB
Int J Pharm; 2001 Apr; 217(1-2):127-37. PubMed ID: 11292549
[TBL] [Abstract][Full Text] [Related]
20. Novel thermosensitive 5-fluorouracil-cyclotriphosphazene conjugates: synthesis, thermosensitivity, degradability, and in vitro antitumor activity.
Cho YW; Lee JR; Song SC
Bioconjug Chem; 2005; 16(6):1529-35. PubMed ID: 16287251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
